Platelets and metastasis revisited: A novel fatty link

Journal of Clinical Investigation

Volumn 114, Issue 12, 2004, Pages 1691-1693

  Gupta, Gaorav P ^a   Massagué, Joan ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID;

ANGIOGENESIS; BONE METASTASIS; BREAST CANCER; CANCER GROWTH; CELL SURVIVAL; HUMAN; METASTASIS POTENTIAL; NONHUMAN; OSTEOLYSIS; OVARY CANCER; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; BIOLOGICAL MODEL; BONE; BREAST TUMOR; DISEASE COURSE; FEMALE; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NOTE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; THROMBOCYTE; TUMOR CELL LINE;

BLOOD PLATELETS; BONE AND BONES; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; LYSOPHOSPHOLIPIDS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOLYSIS; OVARIAN NEOPLASMS;

EID: 15244351844     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200423823     Document Type: Review

References (19)

1. Rickles, F.R., and Falanga, A. 2001. Molecular basis for the relationship between thrombosis and cancer. Thromb. Res. 102:V215-V224.
2. Nash, G.F., Turner, L.F., Scully, M.F., and Kakkar, A.K. 2002. Platelets and cancer. Lancet Oncol. 3:425-430.
3. Karpatkin, S., and Pearlstein, E. 1981. Role of platelets in tumor cell metastases. Ann. Intern. Med. 95:636-641.
4. Nieswandt, B., Hafner, M., Echtenacher, B., and Mannel, D.N. 1999. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 59:1295-1300.
5. Trikha, M., and Nakada, M. T. 2002. Platelets and cancer: implications for antiangiogenic therapy. Semin. Thromb. Hemost. 28:39-44.
6. Boucharaba, A., et al. 2004. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J. Clin. Invest. 114:1714-1725. doi:10.1172/ JCI200422123.
7. Jurasz, P., Alonso-Escolano, D., and Radomski, M.W. 2004. Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br. J. Pharmacol. doi:10.1038/sj.bjp.0706013.
8. FitzGerald, G.A. 1991. Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am J. Cardiol. 68:11B-15B.
9. Brass, L.F. 2003. Thrombin and platelet activation. Chest. 124:18S-25S.
10. Mills, G.B., and Moolenaar, W.H. 2003. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer. 3:582-591.
11. Ishii, I., Fukushima, N., Ye, X., and Chun, J. 2004. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73:321-354.
12. van Corven, E.J., Groenink, A., Jalink, K., Eichholtz, T., and Moolenaar, W.H. 1989. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell. 59:45-54.
13. Mundy, G.R. 2002. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2:584-593.
14. Yin, J.J., et al. 1999. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 103:197-206.
15. Kang, Y., et al. 2003. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 3:537-549.
16. Falanga, A. 2004. The effect of anticoagulant drugs on cancer. J. Thromb. Haemost. 2:1263-1265.
17. Varki, N.M., and Varki, A. 2002. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans. Semin. Thromb. Hemost. 28:53-66.
18. Amirkhosravi, A., et al. 2003. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb. Haemost. 90:549-554.
19. Bakewell, S.J., et al. 2003. Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proc. Natl. Acad. Sci. U. S. A. 100:14205-14210.